Tag Archives: Patient Protection and Affordable Care Act

By Blair Burnett The main topic of discussion at a recent American Health Lawyers Association (AHLA) conference held in Washington, DC focused on initiatives to  reduce overall costs to the healthcare system, and how the pending Patient Protection and Affordable Care Act (PPACA) will further this goal of lowering the cost impact, while providing optimalContinue Reading

When the payment disclosure regulations mandated in the health reform bill (Patient Protection and Affordable Care Act) kick in in January 2012, medical device and pharmaceutical companies will need to act swiftly and carefully to avoid the mistake Harvard University physicians made when they failed to properly disclose industry relationships. To address concerns about theContinue Reading